Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 23 2022 - 9:16AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO SECTION 13A-16 OR 15D-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of May 2022
Commission
File Number: 001-41316
Alpha
Tau Medical Ltd.
(Exact
Name of Registrant as Specified in Its Charter)
Kiryat
HaMada St. 5
Jerusalem, Israel
9777605
+972
(3) 577-4115
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
CONTENTS
On
May 23, 2022, Alpha Tau Medical Ltd. (the “Company”) issued a press release titled “First
Alpha DaRT Patients Treated in France as Part of Alpha DaRT™ Multicenter Skin Cancer Trial.” A copy of this press release
is attached to this Form 6-K as Exhibit 99.1.
The
information in this Report on Form 6-K, including in Exhibit 99.1 attached hereto is being furnished and shall not be deemed
“filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company
under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise set forth herein or as shall be expressly set
forth by specific reference in such a filing.
EXHIBIT INDEX
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
Alpha
Tau Medical Ltd. |
|
|
|
Date:
May 23, 2022 |
By: |
/s/
Uzi Sofer |
|
|
Uzi
Sofer |
|
|
Chief
Executive Officer |
Alpha Tau Medical (NASDAQ:DRTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Alpha Tau Medical (NASDAQ:DRTS)
Historical Stock Chart
From Jul 2023 to Jul 2024